NextCure, Inc. (NXTC) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2018: $7.99M2019: -$35.62M2020: -$44.95M2021: -$57.28M2022: -$53.89M2023: -$52.97M2024: -$40.80M2025: -$49.61M-$49.61M
2018Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$49.61M-21.6%
2024-$40.80M+23.0%
2023-$52.97M+1.7%
2022-$53.89M+5.9%
2021-$57.28M-27.4%
2020-$44.95M-26.2%
2019-$35.62M-545.7%
2018$7.99M